Literature DB >> 18534473

Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement.

Massimiliano Baleani1, Cecilia Persson, Carola Zolezzi, Agnese Andollina, Anna Maria Borrelli, Domenico Tigani.   

Abstract

Antibiotic-loaded bone cement is extensively used in joint arthroplasty, but increasing bacteria resistance against common antibiotics has lead to a demand for alternative drugs. However, bone cement containing new additives must be characterized both biologically and mechanically. This study evaluated elution kinetics, antibacterial activity, and mechanical properties for cement loaded with vancomycin and/or meropenem. The presence of meropenem broadened the antibacterial spectrum and enhanced the elution of vancomycin. The mechanical properties were negatively affected by 1.0 g of vancomycin, but these detrimental effects were acceptable when only 0.5 g of vancomycin were added to a cement containing 0.5 g of meropenem. Further investigations on this formulation with adjusted antibiotic amounts are, however, necessary to reach the optimal compromise between the antibacterial and the mechanical properties of the bone cement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18534473     DOI: 10.1016/j.arth.2007.10.010

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  24 in total

1.  Mechanical effects, antimicrobial efficacy and cytotoxicity of usnic acid as a biofilm prophylaxis in PMMA.

Authors:  Sunghwan Kim; Robert Greenleaf; Mark Carl Miller; Latha Satish; Sandeep Kathju; Garth Ehrlich; J Christopher Post; Nicholas G Sotereanos; Paul Stoodley
Journal:  J Mater Sci Mater Med       Date:  2011-09-22       Impact factor: 3.896

2.  High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE.

Authors:  Joachim Singer; Andreas Merz; Lars Frommelt; Bernd Fink
Journal:  Clin Orthop Relat Res       Date:  2011-11-12       Impact factor: 4.176

Review 3.  Infection in total hip replacement: meta-analysis.

Authors:  Surendra Senthi; Jacob T Munro; Rocco P Pitto
Journal:  Int Orthop       Date:  2010-11-18       Impact factor: 3.075

4.  [Periprosthetic infections following total hip replacement with ESBL-forming bacteria: importance for clinical practice].

Authors:  M Haenle; A Podbielski; M Ellenrieder; R Skripitz; K Arndt; W Mittelmeier; R Bader; H Gollwitzer
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

5.  Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses.

Authors:  Bernd Fink; Sebastian Vogt; Martin Reinsch; Hubert Büchner
Journal:  Clin Orthop Relat Res       Date:  2011-06-16       Impact factor: 4.176

6.  Minimizing dynamic knee spacer complications in infected revision arthroplasty.

Authors:  Aaron J Johnson; Siraj A Sayeed; Qais Naziri; Harpal S Khanuja; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2012-01       Impact factor: 4.176

7.  The use of bone cement for the localized, controlled release of the antibiotics vancomycin, linezolid, or fusidic acid: effect of additives on drug release rates and mechanical strength.

Authors:  John Jackson; Fay Leung; Clive Duncan; Clement Mugabe; Helen Burt
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

Review 8.  [Periprosthetic infection].

Authors:  C Perka; N Haas
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

Review 9.  Revision of late periprosthetic infections of total hip endoprostheses: pros and cons of different concepts.

Authors:  Bernd Fink
Journal:  Int J Med Sci       Date:  2009-09-04       Impact factor: 3.738

Review 10.  Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft.

Authors:  Heinz Winkler
Journal:  Int J Med Sci       Date:  2009-09-04       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.